Archive Category: Green Zone Fortunes Updates

Log In Enter your username and password below USERNAME OR EMAIL PASSWORD Forgot Password?Register Remember...

President Trump’s transformative new trade agenda sent the stock market on a rollercoaster ride over the last two months. And while the S&P 500 has very nearly regained its previous footing — the future of numerous industries and longtime trade partners still hangs in the balance. Meanwhile, trading volume is surging across numerous platforms, with one exchange recording an all-time high of 1.1 billion new contracts in a single quarter.

I designed my Green Zone Power Rating system to give Main Street investors a quick, easy and practical way to beat the market. And it does precisely that, with backtesting showing that our system beats the S&P 500 by a consistent 3-to-1 margin over decades. The system works so well, in fact, that I made it the backbone of this very newsletter. Hence the name, Green Zone Fortunes.

These last six weeks have been a truly unprecedented rollercoaster ride for investors… Stocks started plunging immediately after President Trump’s “Liberation Day” Tariff announcement in early April, logging the fastest-ever 20% decline from all-time highs as panic-selling spread. The mainstream media wasn’t exactly helping either, with countless headlines painting a gloomy picture about what was headed our way.

Last Monday, shares of Hims & Hers Health (HIMS) rocketed more than 30% higher on the announcement of a new deal with Novo Nordisk A/S (NOV), which immediately put Novo’s blockbuster drug Wegovy on Hims’ platform. This recent surge has driven our total gain on HIMS to over 100% since I recommended it in November! Hims has been in a battle with Eli Lilly (LLY) and government regulators to maintain their ability to legally distribute GLP-1 weight loss drugs.